Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
about
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel diseaseInflammatory pathways of importance for management of inflammatory bowel diseaseThe Role of Laboratory Tests in Crohn's DiseaseCurrent status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammationDecreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.Bifidobacteria Abundance-Featured Gut Microbiota Compositional Change in Patients with Behcet's Disease.Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized MedicineAcute Stress Responses Are Early Molecular Events of Retinal Degeneration in Abca4-/-Rdh8-/- Mice After Light ExposureLow dietary iron intake restrains the intestinal inflammatory response and pathology of enteric infection by food-borne bacterial pathogens.Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages.The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.Biological therapy for ulcerative colitis.Update on clinical and research application of fecal biomarkers for gastrointestinal diseases.Pathobiology of neutrophil-epithelial interactions.New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.Neutrophils migrate across intestinal epithelium using beta2 integrin (CD11b/CD18)-independent mechanisms.Consecutive daily measurements of luminal concentrations of lactate in the rectum in septic shock patientsTranscription factor TFEB cell-autonomously modulates susceptibility to intestinal epithelial cell injury in vivo.DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs.Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation.
P2860
Q24669692-6EB46D72-2940-4A03-82BA-1A5ECE0E4E92Q27005445-47A5DF64-BC07-4A60-AE49-BF9783445A06Q28075045-6EF3844A-9C8D-4A76-BF7C-DEC01C055CDFQ34127277-E8267F08-688A-4D08-BC5E-2AED7FEC7E4DQ34408108-F2A5B213-CBC5-4960-97C7-0F1512C2F67CQ34791372-F3AC8814-897F-4FFA-AE4A-961A4FD5A05BQ35594493-863ADFB1-0309-449C-91F2-3C91C419BC46Q35597058-F816D85E-B219-42A3-ACC4-6520041C60C2Q35997058-3B364CF6-973F-4C90-BBED-E9FD88CECD2EQ36052700-CAF5CD22-115D-4525-9DDD-91EC26E9E60FQ36055649-27FEE39D-B5DC-4B1D-B20C-452FA45E175AQ36202128-B77AC254-FEC9-4D1A-9F53-0D367142EBB2Q36780412-83446545-FC6C-43B5-B097-A17F67E31ABEQ37335648-B5B6EF59-F227-436C-BE7D-A5E63931DE7FQ37870433-449532D5-B348-4449-A235-4218E9161943Q38262662-959D2866-E566-404B-B05F-D5C5D15A2326Q38755379-2DE187DE-FF87-4819-B862-DA773BE1A174Q38936511-80C1E81C-644A-4B65-B121-78D5D3CB3881Q38986222-8CD87588-D19B-43FB-9DF2-AC392460D5BAQ39152785-DD63E567-3677-4AE8-86D4-068FFF3AD6FCQ40566570-716D48CA-0755-48C0-BA3A-65A515D796A2Q42619970-6449D5A4-8CE9-484B-BF75-132A7DB86D30Q42636973-829DE411-6B09-431F-B0E5-6056C1AA9BD6Q47863316-17F03CBE-8FE3-4492-9E02-5CC688DAA01CQ50428368-2E74DE15-8A90-4C5E-BBA8-6CB412616784
P2860
Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Rectal dialysate and fecal con ...... r-alpha in ulcerative colitis.
@en
type
label
Rectal dialysate and fecal con ...... r-alpha in ulcerative colitis.
@en
prefLabel
Rectal dialysate and fecal con ...... r-alpha in ulcerative colitis.
@en
P2093
P50
P1476
Rectal dialysate and fecal con ...... or-alpha in ulcerative colitis
@en
P2093
L Kjeldsen
N Borregaard
P2860
P304
P356
10.1111/J.1572-0241.1999.01439.X
P407
P577
1999-10-01T00:00:00Z